GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Nov 2021 05:11 PM
RNS
Total Voting Rights
27 Oct 2021 02:23 PM
RNS
Director/PDMR Shareholding
27 Oct 2021 12:00 PM
RNS
3rd Quarter Results
27 Oct 2021 09:00 AM
RNS
Directorate Change
15 Oct 2021 02:41 PM
RNS
Director/PDMR Shareholding
14 Oct 2021 04:31 PM
RNS
Director/PDMR Shareholding
14 Oct 2021 04:28 PM
RNS
Director/PDMR Shareholding
13 Oct 2021 01:55 PM
RNS
Director/PDMR Shareholding
12 Oct 2021 03:17 PM
RNS
Director/PDMR Shareholding
12 Oct 2021 01:36 PM
RNS
Director/PDMR Shareholding
12 Oct 2021 01:33 PM
RNS
Director/PDMR Shareholding
12 Oct 2021 01:30 PM
RNS
Director/PDMR Shareholding
12 Oct 2021 01:28 PM
RNS
Director/PDMR Shareholding
01 Oct 2021 11:54 AM
RNS
Total Voting Rights
24 Sep 2021 05:28 PM
RNS
Director/PDMR Shareholding
22 Sep 2021 03:58 PM
RNS
Director/PDMR Shareholding
20 Sep 2021 02:42 PM
RNS
Director Declaration
13 Sep 2021 05:26 PM
RNS
Director/PDMR Shareholding
09 Sep 2021 04:42 PM
RNS
Director/PDMR Shareholding
07 Sep 2021 04:54 PM
RNS
Director/PDMR Shareholding
03 Sep 2021 09:32 AM
RNS
Director/PDMR Shareholding
01 Sep 2021 11:44 AM
RNS
Total Voting Rights
31 Aug 2021 07:00 AM
RNS
SK bio & GSK start Ph3 Covid-19 vaccine trial
25 Aug 2021 02:01 PM
RNS
Director/PDMR Shareholding
23 Aug 2021 04:39 PM
RNS
Director/PDMR Shareholding
13 Aug 2021 09:38 AM
RNS
Director/PDMR Shareholding - amendment
11 Aug 2021 02:18 PM
RNS
Director/PDMR Shareholding
11 Aug 2021 12:34 PM
RNS
Director/PDMR Shareholding
05 Aug 2021 09:00 AM
RNS
Block Listing Application
02 Aug 2021 02:23 PM
RNS
Total Voting Rights
28 Jul 2021 05:32 PM
RNS
Director/PDMR Shareholding
28 Jul 2021 12:00 PM
RNS
2nd Quarter Results
26 Jul 2021 04:59 PM
RNS
Director/PDMR Shareholding
23 Jul 2021 02:32 PM
RNS
Board Committee Changes
22 Jul 2021 02:45 PM
RNS
CEO Designate of new Consumer Healthcare company
16 Jul 2021 12:00 PM
RNS
GSK announces daprodustat phase 3 headline results
16 Jul 2021 10:24 AM
RNS
Director/PDMR Shareholding
15 Jul 2021 01:21 PM
RNS
Director/PDMR Shareholding
14 Jul 2021 03:34 PM
RNS
Director/PDMR Shareholding
14 Jul 2021 03:17 PM
RNS
Director/PDMR Shareholding
13 Jul 2021 09:44 AM
RNS
Director/PDMR Shareholding
13 Jul 2021 09:33 AM
RNS
Director/PDMR Shareholding
12 Jul 2021 10:23 AM
RNS
Director/PDMR Shareholding
12 Jul 2021 10:18 AM
RNS
Director/PDMR Shareholding
09 Jul 2021 09:30 AM
RNS
Director/PDMR Shareholding
02 Jul 2021 12:36 PM
RNS
GSK and Alector collaboration in immuno-neurology
02 Jul 2021 10:41 AM
RNS
Elliott Advisors (UK) letter to GSK
01 Jul 2021 02:29 PM
RNS
Total Voting Rights
25 Jun 2021 04:54 PM
RNS
Director/PDMR Shareholding
24 Jun 2021 11:07 AM
RNS
Director/PDMR Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings